At ATS 2025, data from the Phase III MATINEE trial reinforced the efficacy of Nucala in reducing exacerbations in COPD ...

At a recent gathering, experts in the Swiss biotech and pharma sector underscored the power of international collaboration.

The sale brings attention back to privacy concerns as Regeneron now controls genetic data from millions of 23andMe customers.

In April 2025, the European Medicines Agency (EMA) approved Eisai and Biogen’s Leqembi for early-stage Alzheimer’s disease, ...

The US FDA has approved Incyte’s Zynyz (retifanlimab-dlwr) in conjunction with carboplatin and paclitaxel (platinum-based ...

The European Commission (EC) has granted approval to Bristol Myers Squibb’s (BMS) perioperative regimen of neoadjuvant Opdivo ...

Despite early success, however, Novo Nordisk has fallen behind in the GLP-1RA race, overtaken by Eli Lilly and its GLP-1RA ...

Apnimed will be waiting for the readout from a second Phase III trial before it approaches the FDA with an NDA for the sleep apnoea pill.

BioMarin Pharmaceutical has signed a definitive agreement to acquire Inozyme Pharma in an all-cash transaction valued at ...

Imagene is the Innovation award winner in the Precision Oncology category in the 2025 Pharmaceutical Excellence Awards.

Explore Novotech CEO John Moller's insights on the company's global expansion, commitment to diversity, and innovative ...